Net Income

Apparel giant Oxford Industries posts a fiscal year loss after a major writedown, but sees a path to profit driven by a Tommy Bahama resurgence.

Keurig Dr Pepper's upcoming Q1 results are more than just numbers; they're the first look at a company on the brink of a massive transformation.

At a key investor conference, Renibus is pitching its two Phase 3 drugs, including one with a strategic pivot after a challenging trial result.

As GLP-1 drug demand soars, Nordic Cold Chain Solutions launches a new lab to solve the complex puzzle of keeping these sensitive medicines safe.

A new report slams the FDA for blocking vital treatments with rising costs and denials, but the agency faces a complex reality of reform and internal pressure.

A Florida firm says its 15-year study proves 'Hypergrowth Stocks' are a unique asset class. But can a 40% growth metric truly redefine investing?

Cocoa prices are falling, but your chocolate bar costs more. Discover why consumers are embracing this shift by reaching for premium, pricier treats.

An Austin-based firm's rapid expansion to 150 partners shows how CE/CME is moving from conference halls to podcasts, apps, and on-demand platforms.

With $1B in funding and a new virtual cell model, Xaira Therapeutics hires a top dealmaker to turn its AI prowess into pharma partnerships.

A groundbreaking study of 78,000 people shows most with acne and psoriasis manage their conditions alone, outside the clinic. Here's what it means.

WeInfuse launches InfuseTrack, a new platform to end the chaos of manual equipment management and boost safety and compliance in infusion centers.

AI-powered deepfakes bypass tech defenses to exploit human trust, costing firms millions. New research reveals how to fight this emerging cyber threat.

A new wave of drug-free hair restoration combines ancient botanicals with FDA-cleared light therapy, challenging the chemical-reliant status quo.

A troubled mortgage firm is paying shareholders while under a trade ban, revealing a portfolio in distress and raising red flags for Canada's lending sector.

Amid economic uncertainty, TruStage reports over $6.1B in revenue, climbs life insurance ranks, and deepens its fintech and community investments.

Amidst a sea of single-function apps, CWILL's integrated AI platform for DTC brands promises to simplify operations and redefine the customer journey.

A new deal with a top European insurer validates Global AI's advanced platform in a high-stakes market, but can its financials keep pace with its tech?

With a 100% residency match, BayCare is doubling its medical training program, creating a vital pipeline of physicians to serve a rapidly growing Florida.

As the 2026 season begins, MLB reaffirms its historic USO alliance, translating the spirit of baseball into tangible support for military communities.

Western Digital joins an open-source quantum effort, betting its data storage expertise can solve quantum computing's biggest reliability challenge.